Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fixed-Dose Combination (FDC) Products Containing Trazodone and Gabapentin in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Dose Finding Study.

NCT03749642 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.

NCT NCT03749642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03749642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fixed-Dose Combination (FDC) Products Containing Trazodone and Gabapentin in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Dose Finding Study.
Lead sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase
Phase 2
Overall status
Completed
Start date
November 22, 2018
Completion date
June 6, 2020
Enrollment
240 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic neuropathy